Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

The current state of H5N1 vaccines and the use of the ferret model for influenza therapeutic and prophylactic development.

Banner D, Kelvin AA.

J Infect Dev Ctries. 2012 Jun 15;6(6):465-9. Review.

PMID:
22706187
[PubMed - indexed for MEDLINE]
Free Article
2.
3.

Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine.

Rockman S, Brown LE, Barr IG, Gilbertson B, Lowther S, Kachurin A, Kachurina O, Klippel J, Bodle J, Pearse M, Middleton D.

J Virol. 2013 Mar;87(6):3053-61. doi: 10.1128/JVI.02434-12. Epub 2013 Jan 2.

PMID:
23283953
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

IgG antibodies mediate protective immunity of inactivated vaccine for highly pathogenic H5N1 influenza viruses in ferrets.

Shin JS, Kim HS, Cho SH, Seo SH.

Viral Immunol. 2010 Jun;23(3):321-7. doi: 10.1089/vim.2009.0093.

PMID:
20565295
[PubMed - indexed for MEDLINE]
5.

New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.

Poland GA, Fleming DM, Treanor JJ, Maraskovsky E, Luke TC, Ball EM, Poland CM.

Vaccine. 2013 Apr 17;31 Suppl 1:A1-20. doi: 10.1016/j.vaccine.2013.02.033.

PMID:
23587330
[PubMed - indexed for MEDLINE]
6.

Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets.

Bodewes R, Kreijtz JH, Geelhoed-Mieras MM, van Amerongen G, Verburgh RJ, van Trierum SE, Kuiken T, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Virol. 2011 Mar;85(6):2695-702. doi: 10.1128/JVI.02371-10. Epub 2011 Jan 12.

PMID:
21228239
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model.

Ducatez MF, Webb A, Crumpton JC, Webby RJ.

Influenza Other Respir Viruses. 2013 Jul;7(4):506-12. doi: 10.1111/j.1750-2659.2012.00423.x. Epub 2012 Aug 16.

PMID:
22897930
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

Govorkova EA, Webby RJ, Humberd J, Seiler JP, Webster RG.

J Infect Dis. 2006 Jul 15;194(2):159-67. Epub 2006 Jun 9.

PMID:
16779721
[PubMed - indexed for MEDLINE]
Free Article
9.

Evaluation of heterosubtypic cross-protection against highly pathogenic H5N1 by active infection with human seasonal influenza A virus or trivalent inactivated vaccine immunization in ferret models.

Park SJ, Kim EH, Pascua PN, Kwon HI, Lim GJ, Decano A, Kim SM, Song MK, Shin EC, Choi YK.

J Gen Virol. 2014 Apr;95(Pt 4):793-8. doi: 10.1099/vir.0.058636-0. Epub 2014 Jan 13.

PMID:
24421115
[PubMed - indexed for MEDLINE]
10.

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

Mahmood K, Bright RA, Mytle N, Carter DM, Crevar CJ, Achenbach JE, Heaton PM, Tumpey TM, Ross TM.

Vaccine. 2008 Oct 3;26(42):5393-9. doi: 10.1016/j.vaccine.2008.07.084. Epub 2008 Aug 14.

PMID:
18706956
[PubMed - indexed for MEDLINE]
11.

A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.

Itoh Y, Ozaki H, Tsuchiya H, Okamoto K, Torii R, Sakoda Y, Kawaoka Y, Ogasawara K, Kida H.

Vaccine. 2008 Jan 24;26(4):562-72. doi: 10.1016/j.vaccine.2007.11.031. Epub 2007 Dec 3.

PMID:
18164788
[PubMed - indexed for MEDLINE]
12.

Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.

Lalor PA, Webby RJ, Morrow J, Rusalov D, Kaslow DC, Rolland A, Smith LR.

J Infect Dis. 2008 Jun 15;197(12):1643-52. doi: 10.1086/588431.

PMID:
18513153
[PubMed - indexed for MEDLINE]
Free Article
13.

Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin.

Sawai T, Itoh Y, Ozaki H, Isoda N, Okamoto K, Kashima Y, Kawaoka Y, Takeuchi Y, Kida H, Ogasawara K.

Immunology. 2008 Jun;124(2):155-65. doi: 10.1111/j.1365-2567.2007.02745.x. Epub 2008 Jan 16.

PMID:
18205793
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

Kreijtz JH, Suezer Y, van Amerongen G, de Mutsert G, Schnierle BS, Wood JM, Kuiken T, Fouchier RA, Lower J, Osterhaus AD, Sutter G, Rimmelzwaan GF.

J Infect Dis. 2007 Jun 1;195(11):1598-606. Epub 2007 Apr 17.

PMID:
17471429
[PubMed - indexed for MEDLINE]
Free Article
15.

Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.

Pushko P, Pearce MB, Ahmad A, Tretyakova I, Smith G, Belser JA, Tumpey TM.

Vaccine. 2011 Aug 11;29(35):5911-8. doi: 10.1016/j.vaccine.2011.06.068. Epub 2011 Jun 30.

PMID:
21723354
[PubMed - indexed for MEDLINE]
16.

Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets.

Song MS, Oh TK, Pascua PN, Moon HJ, Lee JH, Baek YH, Woo KJ, Yoon Y, Sung MH, Poo H, Kim CJ, Choi YK.

Vaccine. 2009 May 21;27(24):3145-52. doi: 10.1016/j.vaccine.2009.03.061. Epub 2009 Apr 9.

PMID:
19446184
[PubMed - indexed for MEDLINE]
17.

Animal models for the preclinical evaluation of candidate influenza vaccines.

Bodewes R, Rimmelzwaan GF, Osterhaus AD.

Expert Rev Vaccines. 2010 Jan;9(1):59-72. doi: 10.1586/erv.09.148. Review.

PMID:
20021306
[PubMed - indexed for MEDLINE]
18.

New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.

Steel J.

BioDrugs. 2011 Oct 1;25(5):285-98. doi: 10.2165/11593870-000000000-00000. Review.

PMID:
21942913
[PubMed - indexed for MEDLINE]
19.

H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines.

Cheng X, Eisenbraun M, Xu Q, Zhou H, Kulkarni D, Subbarao K, Kemble G, Jin H.

PLoS One. 2009;4(2):e4436. doi: 10.1371/journal.pone.0004436. Epub 2009 Feb 11.

PMID:
19209231
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets.

Baras B, Stittelaar KJ, Kuiken T, Jacob V, Bernhard R, Giannini S, de Waal L, van Amerongen G, Simon JH, Osterhaus AD, Hanon E, Mossman SP.

Vaccine. 2011 Mar 3;29(11):2092-9. doi: 10.1016/j.vaccine.2010.12.128. Epub 2011 Jan 13.

PMID:
21237275
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk